Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,430 | -83,118 | -64,544 | -43,698 | -52,859 |
| Depreciation Amortization | -82 | 187 | 549 | 733 | 171 |
| Other Working Capital | -980 | 4,290 | 3,027 | -1,363 | 272 |
| Other Operating Activity | 6,786 | 10,624 | 10,254 | 11,580 | 22,961 |
| Operating Cash Flow | $-64,706 | $-68,017 | $-50,714 | $-32,748 | $-29,455 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,570 | 38,451 | 54,530 | 35,073 | -29,270 |
| PPE Investments | -81 | -196 | -329 | -386 | -200 |
| Purchase Of Investment | N/A | N/A | -104,954 | -10,468 | N/A |
| Investing Cash Flow | $-8,651 | $38,255 | $-50,753 | $24,219 | $-29,470 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 158,677 | 2,652 | 144,367 | 887 | 54,757 |
| Financing Cash Flow | $158,677 | $2,652 | $144,367 | $887 | $54,757 |
| Beginning Cash Position | 22,383 | 49,493 | 6,593 | 14,235 | 18,403 |
| End Cash Position | 107,703 | 22,383 | 49,493 | 6,593 | 14,235 |
| Net Cash Flow | $85,320 | $-27,110 | $42,900 | $-7,642 | $-4,168 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,706 | -68,017 | -50,714 | -32,748 | -29,455 |
| Capital Expenditure | -81 | -196 | -329 | -386 | -204 |
| Free Cash Flow | -64,787 | -68,213 | -51,043 | -33,134 | -29,659 |